Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP

Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, Søren Knak Jacobsen, Kristian Stengaard-Pedersen, Peter Junker, Tine Lottenburger, Ib Tønder Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Jørgen Svendsen, Jens Kristian Pedersen, Henrik Skjødt, Torkell Juulsgaad Ellingsen, Hanne Lindegaard, Jan Pødenphant, Kim Hørslev-Petersen, CIMESTRA study group

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

To investigate the short-term and long-term efficacy of intra-articular betamethasone injections, and the impact of joint area, repeated injections, MRI pathology, anticyclic citrullinated peptide (CCP) and immunoglobulin M rheumatoid factor (IgM-RF) status in patients with early rheumatoid arthritis (RA).
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume71
Issue number6
Pages (from-to)851-6
Number of pages6
ISSN0003-4967
DOIs
Publication statusPublished - 2012

Keywords

  • Anti-Inflammatory Agents
  • Arthritis, Rheumatoid
  • Autoantibodies
  • Betamethasone
  • C-Reactive Protein
  • Drug Therapy, Combination
  • Early Diagnosis
  • Follow-Up Studies
  • Glucocorticoids
  • Humans
  • Immunoglobulin M
  • Injections, Intra-Articular
  • Joints
  • Magnetic Resonance Imaging
  • Peptides, Cyclic
  • Proportional Hazards Models
  • Recurrence
  • Rheumatoid Factor
  • Time
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP'. Together they form a unique fingerprint.

Cite this